Clinical Trial Update: Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial named Clear Me aims to detect and clear molecular residual disease in high-risk melanoma and is currently recruiting, including cutaneous and mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma
• Mucosal Melanoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cutaneous Melanoma, Melanoma Stage IV | Phase 2 | Status: RECRUITING